Series E · $300M
$300M Series E.
Editorial intelligence brief
Abridge is expanding its contextual reasoning and clinical documentation platform across major health systems.
Focus: Generative AI clinical documentation and healthcare conversation intelligence
Latest funding
$300M
Series E · source-backed
Tracked funding
$300M
Sum of itemized funding events
Latest valuation
Not tracked
No source-backed record
Latest revenue
Not tracked
Growth lifecycle position
Source-backed financial history
Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.
Records
1
Tracked total
$300M
Coverage
partial
Series E · $300M
Running tracked total: $300M
Every numbered chart marker maps to one source-linked funding announcement below.
Series E · $300M
$300M Series E.
Chronological activity
Abridge is expanding its contextual reasoning and clinical documentation platform across major health systems.
A structured event record is still being assembled for this company.
The Healthcare Technology Report. · Jun 25
Chicago Star Media · Jun 18
TradingPedia · 10 related sources · Jun 11
Product surface
Recent models
No standalone model family is structured for this profile.
Products
Open weights
No
API access
No
Review cadence
Weekdays
Market position
Research
Preview
Growth
Deployment
Growth: Public access & scaling
Focus
Generative AI clinical documentation and healthcare conversation intelligence
Signals
Taxonomy
Competitive context
Infrastructure & distribution
Model layer
No standalone model family tracked
Access layer
Application or managed product
Market layer
Vertical + Enterprise
Public product surface
Stack signals
This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.
Evidence trail
Primary and public sources used to verify the structured company profile.
The Staticbreaker
The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.